Curi RMB Capital’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,585
Closed -$455K 781
2019
Q3
$455K Sell
4,585
-45
-1% -$4.28K 0.01% 495
2019
Q2
$428K Sell
4,630
-961
-17% -$91.3K 0.01% 577
2019
Q1
$527K Sell
5,591
-1,871
-25% -$164K 0.01% 563
2018
Q4
$478K Sell
7,462
-1,499
-17% -$111K 0.01% 652
2018
Q3
$802K Buy
8,961
+506
+6% +$44.7K 0.02% 540
2018
Q2
$672K Buy
8,455
+148
+2% +$12.3K 0.02% 582
2018
Q1
$741K Sell
8,307
-1,078
-11% -$103K 0.02% 556
2017
Q4
$979K Sell
9,385
-48,234
-84% -$5.44M 0.03% 482
2017
Q3
$8.4M Sell
57,619
-504
-0.9% -$68.7K 0.22% 146
2017
Q2
$7.55M Buy
58,123
+53,191
+1,078% +$6.52M 0.22% 146
2017
Q1
$614K Buy
4,932
+1,500
+44% +$180K 0.03% 350
2016
Q4
$397K Sell
3,432
-876
-20% -$97.6K 0.02% 341
2016
Q3
$450K Sell
4,308
-194
-4% -$21K 0.02% 310
2016
Q2
$444K Sell
4,502
-7
-0.2% -$724 0.02% 319
2016
Q1
$451K Sell
4,509
-70,631
-94% -$7.27M 0.03% 278
2015
Q4
$9M Sell
75,140
-3,691
-5% -$427K 0.41% 62
2015
Q3
$8.53M Sell
78,831
-1,105
-1% -$137K 0.57% 54
2015
Q2
$9.25M Buy
79,936
+808
+1% +$92.4K 0.6% 51
2015
Q1
$9.12M Buy
79,128
+75,675
+2,192% +$9.04M 0.55% 56
2014
Q4
$386K Hold
3,453
0.02% 359
2014
Q3
$327K Buy
3,453
+703
+26% +$63.4K 0.02% 377
2014
Q2
$236K Buy
+2,750
New +$209K 0.01% 387

Other funds holding CELG

Curi RMB Capital's CELG Position: Q4 2019 in Review

Curi RMB Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,585 shares — an estimated $455K sold.

Curi RMB Capital first reported a position in CELG in Q2 2014 and held it in 22 quarters. The position peaked at $9.25M in Q2 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Curi RMB Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Curi RMB Capital sold 4,585 Celgene Corp shares in Q4 2019, an estimated $455K.
  • Curi RMB Capital first reported a position in Celgene Corp in Q2 2014 and held it in 22 quarters.
  • Curi RMB Capital's Celgene Corp position peaked at $9.25M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Curi RMB Capital's 13F filing for Q4 2019, filed 13 Feb 2020.